Xconomy National

Archives

by in

Entry	Author	Date	Location
Seattle Genetics Sees Updated Side Effect Warning in Drug Label	Luke Timmerman	01/13/12	Seattle
Seattle Genetics Sees Case of PML, Causing Market Twitch	Luke Timmerman	12/01/11	Seattle
ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer	Ryan McBride	02/25/11	Boston
Calistoga Rolls Out More Evidence For Blood Cancer Drug, Sizes Up Pivotal Trial	Luke Timmerman	12/05/10	Seattle
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s	Luke Timmerman	12/05/10	Seattle
Dendreon’s Commercial Point Man Exits In Year One of Provenge Launch	Luke Timmerman	11/18/10	Seattle
Roche Cuts to Hit Hundreds of Genentech Workers; Scientific Staff is Spared	Luke Timmerman	11/17/10	San Francisco
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News	Erin Kutz	11/05/10	Boston
Biogen Idec Axes 650 Jobs, Closes San Diego Site, Bets Future on Neurology	Luke Timmerman	11/03/10	Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News	Erin Kutz	10/22/10	Boston
Biogen, Genentech Revamp Alliance	Luke Timmerman	10/21/10	San Francisco
Calistoga Starts Mid-Stage Trial	Luke Timmerman	10/19/10	Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer	Luke Timmerman	09/27/10	Seattle
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader	Luke Timmerman	08/17/10	San Francisco
Novartis Test Drives Biotech Startup Adimab’s Drug Discovery Engine	Ryan McBride	07/09/10	Boston
Genentech’s Souped-Up Herceptin: The Odyssey Toward a More Powerful Breast Cancer Drug	Luke Timmerman	06/14/10	San Francisco
Calistoga Pharmaceuticals Builds Stronger Case for Blood Cancer Drug	Luke Timmerman	06/07/10	Seattle
Trubion Wins Genentech, Biogen Patent Case	Luke Timmerman	06/03/10	Seattle
Seattle Genetics, Growing Up in a Hurry With Millennium, Aims to Make Most of Cancer Drug	Luke Timmerman	05/26/10	Seattle
Dendreon Makes History: FDA Approves First Active Immune-Booster to Fight Cancer	Luke Timmerman	04/29/10	Seattle
Dendreon Hires Roche Sales Boss	Luke Timmerman	04/08/10	Seattle
FDA Cancer Drug Boss Slams Cell Therapeutics Application For Lymphoma Drug	Luke Timmerman	03/22/10	Seattle
Roche, Biogen Halt Arthritis Study	Luke Timmerman	03/08/10	Boston
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO	Luke Timmerman	01/07/10	Boston
Adimab Proves Fast Antibody Discovery Tool to Merck, Roche; Snags New Deal With Pfizer	Luke Timmerman	12/17/09	Boston
Roche Scraps Partnership With Seattle Genetics on Lymphoma Drug	Luke Timmerman	12/11/09	Seattle
Dendreon Grasps for $400M, ZymoGenetics Cuts 52 Jobs, Calistoga Advances at ASH, & More Seattle-Area Life Sciences News	Luke Timmerman	12/10/09	Seattle
Biogen Idec’s Dream: Antibodies That Kill Two Birds With One Stone	Luke Timmerman	12/09/09	Boston
Seattle Genetics, Genentech Lymphoma Drug Passes Early Test with “Naked” Antibody	Luke Timmerman	12/07/09	Seattle
Tysabri, the MS Drug Haunted by Deadly Side Effect, Doesn’t Look So Deadly Anymore	Luke Timmerman	11/19/09	Boston
Page 1 of 2	next page »